Diversified Healthcare Trust (NASDAQ:DHC) has a beta value of 1.73 and has seen 3.42 million shares traded in the last trading session. The company, currently valued at $178.10M, closed the last trade at $0.78 per share which meant it gained $0.02 on the day or 2.02% during that session. The DHC stock price is -320.51% off its 52-week high price of $3.28 and 21.79% above the 52-week low of $0.61. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.35 million shares traded. The 3-month trading volume is 4.04 million shares.
The consensus among analysts is that Diversified Healthcare Trust (DHC) is a Hold stock at the moment, with a recommendation rating of 3.20. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 4 have rated it as a Hold, with 1 advising it as a Buy. 1 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.24.
Diversified Healthcare Trust (NASDAQ:DHC) trade information
Sporting 2.02% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Monday, 01/23/23 when the DHC stock price touched $0.78 or saw a rise of 3.7%. Year-to-date, Diversified Healthcare Trust shares have moved 20.18%, while the 5-day performance has seen it change 4.35%. Over the past 30 days, the shares of Diversified Healthcare Trust (NASDAQ:DHC) have changed 20.14%. Short interest in the company has seen 6.99 million shares shorted with days to cover at 3.24.
Diversified Healthcare Trust (DHC) estimates and forecasts
Figures show that Diversified Healthcare Trust shares have underperformed across the wider relevant industry. The company’s shares have lost -56.08% over the past 6 months, with this year growth rate of -600.00%, compared to 4.90% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2023 fiscal year revenue. Growth estimates for the current quarter are 36.80% and 42.50% for the next quarter. Revenue growth from the last financial year stood is estimated to be -8.00%.
4 analysts offering their estimates for the company have set an average revenue estimate of $320.79 million for the current quarter. 4 have an estimated revenue figure of $328.53 million for the next quarter concluding in Dec 2022. Year-ago sales stood $337.42 million and $336.73 million respectively for this quarter and the next, and analysts expect sales will shrink by -4.90% for the current quarter and -2.40% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 4.30% over the past 5 years. Earnings growth for 2023 is a modest 225.00% while over the next 5 years, the company’s earnings are expected to increase by 3.20%.
Diversified Healthcare Trust is expected to release its next earnings report between February 21 and February 27 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 0.04 at a share yield of 5.15%. The company’s dividend yield has gone up over the past 12 months.
Diversified Healthcare Trust (NASDAQ:DHC)’s Major holders
Insiders own 1.35% of the company shares, while shares held by institutions stand at 84.34% with a share float percentage of 85.49%. Investors are also buoyed by the number of investors in a company, with Diversified Healthcare Trust having a total of 332 institutions that hold shares in the company. The top two institutional holders are Blackrock Inc. with over 40.81 million shares worth more than $74.28 million. As of Jun 29, 2022, Blackrock Inc. held 17.07% of shares outstanding.
The other major institutional holder is Vanguard Group, Inc. (The), with the holding of over 38.87 million shares as of Jun 29, 2022. The firm’s total holdings are worth over $70.75 million and represent 16.26% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Core S&P Smallcap ETF and Vanguard Specialized-Real Estate Index Fund. As of Sep 29, 2022, the former fund manager holds about 7.50% shares in the company for having 17.95 million shares of worth $17.77 million while later fund manager owns 10.94 million shares of worth $18.92 million as of Jul 30, 2022, which makes it owner of about 4.57% of company’s outstanding stock.